Breast & Ovarian Cancer: BRCA1 and BRCA2

Slides:



Advertisements
Similar presentations
Part Two Welcome back. Familial Cancer Genetics Cancer Genetics 5-10% of all cancer clearly linked to an inherited gene alteration If cancer seen at.
Advertisements

Gene 210 Cancer Genomics April 29, Key events in investigating the cancer genome M R Stratton Science 2011;331:
A few thoughts on cancer and cancer family syndromes Pamela McGrann, MD. Department of Medical Genetics.
What is Li-Fraumeni syndrome?
Hereditary Factors in Breast Cancer
Investigating the BRCA1 Mutation F.R.E.S.H Docs. Angelina Jolie Actress, Film director, and Screenwriter Mother had Breast Cancer and died at 56 from.
Hereditary breast and ovarian cancer Who should be screened and How? Symposium on Cancer Waterloo Inn October 31, 2007 Mala Bahl, MD, MSc.
Hereditary Breast & Ovarian Cancer Syndrome HBOC Tammy McKamie RN MSN OCN Cancer Genetics Educator Clinical Oncology Patient Navigator.
Breast Cancer Risk and Risk Assessment Models
A signal transducer and cancer Neurofibromin, ras, and cancer - utah.
The Contribution of the BRCA1 and BRCA2 Genes to Hereditary Breast Cancer and Ovarian Cancer in Israel Tieling Wang Department of Human Genetics Hadassah.
Type Of Cancer:Location: CarcinomaEpithelial Cells SarcomaConnective Tissue LeukemiaCirculatory / Lymphatic.
Gene 210 Cancer Genomics May 5, Key events in investigating the cancer genome M R Stratton Science 2011;331:
Introduction to Genetics, with a Focus on Human Genetics.
DNA marker analysis Mrs. Stewart Medical Interventions Central Magnet School.
Cancer Genetics for Primary Care Sara Levene Registered Genetic Counsellor.
PCR Application: Can Breast Cancer be Cured?. Normal, Healthy Cells Cells can change or differentiate to become specialised according to the tissue that.
Breast Cancer Awareness Month October is Breast Cancer Awareness Month. While most people are aware of breast cancer, many forget to take the steps to.
Breast Cancer 101 Barbara Lee Bass, MD, FACS Professor of Surgery
BRCA Genes Dallas Henson.
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Breast Screening. NHS Breast Screening Programme Introduced in 1988 Invites women from age group for screening every 3 yrs. Age extension roll-out.
Breast Cancer By George Rezk.
BREAST CANCER Research done by Jazmine Warden and David Iheanacho.
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
SUMAYYA EBRAHIM GYNAECOLOGIST PARKLANE CLINIC JOHANNESBURG
GENETIC TESTING: WHAT DOES IT REALLY TELL YOU? Lori L. Ballinger, MS, CGC Licensed Genetic Counselor University of New Mexico Cancer Center.
Another way to think of cancer is “Mitosis Run Amok.”
Cancer.
Breast Cancer Methods for Early Detection. Breast Cancer What It Is Methods of Early Detection Risk Factors.
Angelina Jolie The White Coat Wonder. Rational  The purpose of our research is to enrich the Premed-A community with the knowledge of other cancers caused.
Last lesson we looked at: What is the definition of a gene?
Breast Cancer By: Christen Scott.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
BRCA1 and BRCA2 are genes which normally help to prevent breast cancer by making proteins which inhibit abnormal cellular growth. While a woman with an.
Breast Ovarian Hereditary Breast & Ovarian Cancer Knowing one’s family medical history can be life-saving.
Breast Cancer and BRCA2. 1 million women worldwide diagnosed. 1 out of 12 women in Western Europe and the United States 30% mortality rate Highest cause.
Genetics: For this Generation and the Next
CASE #574321F – The Ford Family
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Breast Cancer: BRCA1/2 Erin Hayes Foundations of Medicine Blue Valley CAPS October 28,
Changes in the Eukaryotic Genome By: Sergio Aguilar.
Javad Jamshidi Fasa University of Medical Sciences, December 2015 Cancer Genetics Session 4 Medical Genetics.
Cancer Cell Division Gone Wrong!. Cancer is not just one disease, but many diseases – over 200 different types of cancers.
Breast Cancer Ten percent of breast cancer is hereditary. Or 23,000 women a year with a genetic basis for their cancer. The most common mutations in this.
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
IV. Human Autosomal Genetic Diseases. Who cares about pea plants? Mendel’s pea plant studies led the way to the basic understanding of genetics (Three.
What Percentage of Cancer is Considered to be Hereditary?
By: Anthony, Sophia, Jessica, Terrance, and Sierra.
Genomic Medicine Rebecca Tay Oncology Registrar. What is Genomic Medicine? personalised, precision or stratified medicine.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
The Elliott Breast Center * Baton Rouge, LA *
BLOOM’S SYNDROME Matt Hefner. Bloom’s Syndrome Bloom’s Syndrome is a genetic disorder resulting from a genetic mutation on the 15th chromosome. It Bloom’s.
Cell Division Gone Wrong Cancer.  Cancer is a disease of uncontrolled cell division. It starts with a single cell that loses its control mechanisms due.
3.2 Review MI. In what ways do different risk factors increase the chance that a person will develop cancer? How can lifestyle changes reduce the risk.
Hereditary Cancer Predisposition: Updates in Genetic Testing
Pathways involved in hereditary breast cancer
Screening for Ovarian Cancer
Karyotyping Cancer.
Male and Female Reproductive Health Concerns
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Who in the room would offer BRCA1/2 testing to this patient Who in the room would offer BRCA1/2 testing to this patient? How might the medical management.
What makes a mutant?.
Errors in DNA Mutations.
Genetic Counseling & Testing for Cancer Risk
Specific Tumor Suppressor Genes
Presentation transcript:

Breast & Ovarian Cancer: BRCA1 and BRCA2 Jennifer Hardee

Normal function of the genes BRCA1 & BRCA2 are in the same DNA repair pathway Despite names, do not share any protein structure Both are tumor suppressors Losing their function promotes cancer They help repair double-strand breaks in DNA Promote homologous recombination as the repair mechanism of choice Pathway includes many other genes, including CHEK2

Loading the dice For cancer to occur, a cell must accumulate a series of mutations over time In BRCA carriers, the 1st mutation has already happened in every cell Loss of heterozygosity (LOH) takes out the remaining good copy of the gene: The good allele is damaged in one cell by a mutagen or copying mistake The mutated allele is used as a template to repair it Suddenly, both copies of the gene are defective

Breast cancer karyotype Cells gone wild Show us your telomeres! When DNA damage goes unfixed, the cell starts repairing it any way it can Often introduces new mutations in the process Broken chromosomes may be stitched back together incorrectly Inevitably, some genes that control growth are affected Breast cancer karyotype

What are the mutations? Hundreds of mutations have been found in both BRCA genes The damaging mutations usually lead to truncated proteins Frameshifts are common Mostly occur de novo But there are strong “founder effect” mutations in some populations 1.4% 0.1% 1.0% vs. 0.5%

How are they inherited? Carriers generally have one mutated copy of the gene Inheritance pattern is dominant and autosomal All children, regardless of sex, have a 50% chance of inheriting the mutated allele Any child that does inherit the mutant allele will bear all the risks associated with it Men are often considered “silent carriers” but this is overly simplistic

What is their effect? BRCA families suffer from hereditary breast-ovarian cancer syndrome (HBOC) Defects increase cancer risk for: Women: breasts, ovaries, fallopian tubes (rare) Men: prostate, testicles Both: pancreatic cancer, malignant melanoma, glioblastoma, some lymphomas Why do BRCA mutations preferentially affect these organ systems? We don’t know.

Lifetime cancer risk for women 12 / 60/ 50 2 / 40 / 20

Breast cancer Penetrance: 50-60% of BRCA carriers will develop breast cancer, compared to 12% of all women BRCA1 carrier BRCA2 carrier Cancer appears 20 years earlier than normal More often “triple-negative” No ER, PR, or Her2 Cannot be treated with hormone therapy or herceptin Cancer usually appears after menopause Can show up earlier, but danger spikes at menopause Usually ER or PR positive Vulnerable to hormone therapy

Ovarian cancer Especially deadly because it’s hard to catch Penetrance: 20-40% of BRCA carriers will develop ovarian cancer, compared to 2% of all women Especially deadly because it’s hard to catch Blood test is often wrong 60% of cases are caught at Stage III or IV BRCA tumors are more aggressive and have poorer prognoses

Risks to male carriers Relative risk of breast cancer is high Absolute risk is still low Cancers with elevated risk for both sexes: Pancreatic, melanoma, glioblastoma, lymphoma BRCA2 also increases prostate cancer risk 1.5-4x These cancers may be more aggressive 0.1 / 2 / 6 / 12

Who should get tested? Anyone: With a close relative who has tested positive With a strong family history of breast or ovarian cancer Whose mother/daughter had cancer in both breasts This applies to about 2% of adults In cases of family history, it’s best to first test one of the people who has had the disease (if possible) If s/he tests positive, then other family members should also consider getting the test Family history requirement is less stringent for people from ethnic groups with known founder-effect mutations

Testing, testing, 1-2-3 About 10% of breast and ovarian cancer patients carry a BRCA1 or BRCA2 mutation 23andMe tests for 10 specific mutations: CASP8, CHEK2, FGFR2, STXBP4, 2q35, 3p24, 16q12 BRCA1 185delAG, BRCA1 5382insC, BRCA2 6174delT Lots of other mutations are known e.g. BRCA2 999del5 in Iceland So why doesn’t 23andMe test for them?

Limitations of testing Testing for BRCA1 and BRCA2 is not straightforward There are no “hot spots”: dangerous mutations can occur almost anywhere in the exons or introns Human Gene Mutation Database lists 1,433 known mutations for BRCA1 and 1,183 for BRCA2 To be thorough, you would need: A test that sequenced the entire gene that checked against a database of known mutations and evaluated unknown mutations for risk based on how they changed the gene

Testing positive

What are the options? There are three major options for carriers: Increased screening Preventative medication Prophylactic surgery Most women opt for a combination of approaches Lifestyle changes that reduce cancer risk in other women often do not provide meaningful protection to BRCA carriers

1. Surveillance screening Goal is to find cancer early, when it’s most treatable Does not lower lifetime risk of developing cancer Breast cancer Ovarian cancer Clinical breast exams Mammograms Men, too! MRI of the breast Clinical abdominal exams Transvaginal ultrasound CA-125 blood test High rates of false +/-

2. Preventative medication Goal is to reduce the risk of developing cancer Tamoxifen is an estrogen blocker that lowers breast cancer risk by about 50% Has unpleasant side effects, e.g. pseudo-menopause Hormonal birth control for ~5 years in your late 20’s reduces ovarian cancer risk Timing ensures minimal increase to breast cancer risk

3. Prophylactic surgery Goal is to actively prevent cancer by removing “at risk” tissue while it’s still healthy Recommended procedures for BRCA carriers: Double mastectomy (both breasts) Salpingo-oophorectomy (ovaries and fallopian tubes) Mastectomy causes disfigurement and loss of nerves/feeling Best procedure is incompatible with plastic surgery Oophorectomy causes infertility and early menopause Recommended at around age 45

What if…? What if you thought your family carried a BRCA mutation? Would you get tested? Encourage your relatives? If positive, what treatments would you choose? How would it affect your future life choices?